358 related articles for article (PubMed ID: 25112726)
1. DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.
Esposito MT; So CW
Chromosoma; 2014 Dec; 123(6):545-61. PubMed ID: 25112726
[TBL] [Abstract][Full Text] [Related]
2. The Role of DNA Repair Pathways in AML Chemosensitivity.
Pearsall EA; Lincz LF; Skelding KA
Curr Drug Targets; 2018; 19(10):1205-1219. PubMed ID: 29318968
[TBL] [Abstract][Full Text] [Related]
3. Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
Pennisi R; Albanesi J; Ascenzi P; Nervi C; di Masi A
IUBMB Life; 2018 Nov; 70(11):1057-1066. PubMed ID: 30296357
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
[TBL] [Abstract][Full Text] [Related]
5. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
[No Abstract] [Full Text] [Related]
6. Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias.
Popp HD; Naumann N; Brendel S; Henzler T; Weiss C; Hofmann WK; Fabarius A
Leuk Res; 2017 Jun; 57():112-118. PubMed ID: 28359030
[TBL] [Abstract][Full Text] [Related]
7. DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
Hubner SE; de Camargo Magalhães ES; Hoff FW; Brown BD; Qiu Y; Horton TM; Kornblau SM
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982970
[TBL] [Abstract][Full Text] [Related]
8. Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.
Gotoh N; Saitoh T; Takahashi N; Kasamatsu T; Minato Y; Lobna A; Oda T; Hoshino T; Sakura T; Shimizu H; Takizawa M; Handa H; Yokohama A; Tsukamoto N; Murakami H
Int J Hematol; 2018 Sep; 108(3):246-253. PubMed ID: 29737460
[TBL] [Abstract][Full Text] [Related]
9. Zinc Prevents DNA Damage in Normal Cells but Shows Genotoxic and Cytotoxic Effects in Acute Myeloid Leukemia Cells.
Costa MI; Lapa BS; Jorge J; Alves R; Carreira IM; Sarmento-Ribeiro AB; Gonçalves AC
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269710
[TBL] [Abstract][Full Text] [Related]
10. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
[TBL] [Abstract][Full Text] [Related]
11. Combined immune and DDR pathway classifier: A novel pathway-based classification aimed at tailoring personalized therapies for acute myeloid leukemia patients.
Huang Y; Zhang Y; Zhou Q; Teng Y; Sui M; Zhang F
Comput Biol Med; 2023 Aug; 162():107093. PubMed ID: 37269679
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia.
Seedhouse C; Faulkner R; Ashraf N; Das-Gupta E; Russell N
Clin Cancer Res; 2004 Apr; 10(8):2675-80. PubMed ID: 15102670
[TBL] [Abstract][Full Text] [Related]
13. DNA damage signalling guards against activated oncogenes and tumour progression.
Bartek J; Bartkova J; Lukas J
Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
[TBL] [Abstract][Full Text] [Related]
14. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of spongean alkaloids on mechanisms of cell death, cell cycle progression and DNA damage response (DDR) of acute myeloid leukemia (AML) cells.
Stuhldreier F; Kassel S; Schumacher L; Wesselborg S; Proksch P; Fritz G
Cancer Lett; 2015 May; 361(1):39-48. PubMed ID: 25697484
[TBL] [Abstract][Full Text] [Related]
16. RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2‑deficient human acute myeloid leukemia.
Xu Y; Lin Y; Luo Y; Yang Y; Long B; Fang Z; Liu L; Zhang J; Zhang X
Oncol Rep; 2020 Oct; 44(4):1455-1466. PubMed ID: 32945515
[TBL] [Abstract][Full Text] [Related]
17. hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy.
Xu R; Yu S; Zhu D; Huang X; Xu Y; Lao Y; Tian Y; Zhang J; Tang Z; Zhang Z; Yi J; Zhu HH; Zheng X
Nat Commun; 2019 Aug; 10(1):3812. PubMed ID: 31444354
[TBL] [Abstract][Full Text] [Related]
18. DNA damage response inhibitors: An avenue for TNBC treatment.
Jin J; Tao Z; Cao J; Li T; Hu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
[TBL] [Abstract][Full Text] [Related]
19. Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance.
Staudt D; Murray HC; McLachlan T; Alvaro F; Enjeti AK; Verrills NM; Dun MD
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332834
[TBL] [Abstract][Full Text] [Related]
20. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
